Products

Image description

FDA approves GSK's Arnuity Ellipta

GlaxoSmithKline announced FDA approval for Arnuity Ellipta (fluticasone furoate inhalation powder), a once-daily inhaled corticosteroid medicine for the treatment of asthma in patients 12 years of age and older.

Image description

Iconic brands stage a comeback

There are a number of growth drivers across the digestives space, starting with the biggest proton-pump inhibitor to make its way from behind the pharmacy bench to over-the-counter aisles since the original “Purple Pill” was switched in 2003.

Image description

Sensory delivery becomes trendy

Pharmavite’s VitaMelts brand has been a popular introduction to the category, with $9.4 million in sales, up 184.3%, for the 52 weeks ended June 15 across total U.S. multi-outlets, according to IRI.

Image description

Estroven attracts new users

The successful introduction of Estroven Weight Management is bringing new users to the menopause supplement category, said April Mills, marketing director of i-Health, a division of DSM.